Sanuwave Health (SNWV) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
11 Jun, 2026Opening remarks and agenda
Meeting called to order by CEO, with CFO appointed as secretary and inspector of election designated.
Agenda and voting procedures reviewed, with encouragement to review agenda online.
Notice of meeting mailed to stockholders on April 29, 2026.
Board and executive committee updates
Five directors nominated for election to serve until the 2027 annual meeting.
Shareholder proposals
Five proposals presented, including election of directors, ratification of accounting firm, and advisory vote on executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Sanuwave Health
- Q1 2026 set a revenue record with improved net loss and strong outlook for continued growth.SNWV
Q1 202613 May 2026 - Annual meeting to vote on directors, auditor, and executive pay, with strong governance focus.SNWVProxy filing29 Apr 2026
- Key votes include director elections, auditor ratification, and executive pay approval.SNWVProxy filing29 Apr 2026
- Record 2025 revenue and profit, with strong UltraMIST sales and robust 2026 growth outlook.SNWVQ4 202527 Mar 2026
- Record Q2 revenue and net income, with strong Q3 growth expected but ongoing capital risks.SNWVQ2 20242 Feb 2026
- Merger deadline extended, Cboe listing targeted, and 50% revenue growth forecast.SNWVM&A Announcement31 Jan 2026
- Q3 revenue up 89% to $9.4M, margin gains, but going concern risks persist.SNWVQ3 202415 Jan 2026
- Record revenue, margin gains, and 2025 guidance for 47–53% growth signal strong momentum.SNWVQ4 202426 Dec 2025
- Shareholders to vote on director elections, auditor, equity plan, and executive pay at annual meeting.SNWVProxy Filing2 Dec 2025